VI. Committee Recommendations 
In developing the following recommendations, the Interagency Committee 
on Recombinant DNA Research considered the activities to date of national, 
regional, and international scientific organizations and governmental health 
and safety organizations. Also, a concerted effort was made to obtain the 
most comprehensive possible survey of international activities related to 
recombinant DNA research. The survey of activities, prepared by NIH staff, 
was circulated by the State Department to all U.S. science attaches abroad, 
with a request to update the report and to supply any information available 
on governmental actions taken to legislate or regulate recombinant DNA 
activities. The survey, which appears as Part B, includes all relevant 
information received by the State Department. 
Professor William J. Whelan, Chairman of the Committee on Genetic 
Experimentation of the International Council of Scientific Unions, attended 
both meetings of the Subcommittee and briefed it on the actions of his 
Committee and of other international scientific organizations. Further, a 
number of NIH officials reported on extensive NIH activities of interrelat- 
ing U.S. efforts with those of WHO and European organizations such as the 
European Molecular Biology Organization, the European Science Foundation, 
and the European Medical Research Councils. After review and discussion 
of all the information obtained, the following recommendations are made: 
• In light of the activities of national, regional, and international 
organizations, the Committee recommends that cognizant Federal 
agencies continue to work in close cooperation with such organiza- 
tions as ESF, EMBO, EMRC, WHO, and ICSU. The Committee takes special 
13 
[ 397 ] 
